945 Půjčovatel komín cd38 m1 marker stimulovat Brandy před
CD38 and Regulation of the Immune Response Cells in Cancer
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
Frontiers | CD38: A Significant Regulator of Macrophage Function
Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19 | Scientific Reports
M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors | ACS Nano
Frontiers | CD38: A Significant Regulator of Macrophage Function
Mechanism of CD38 via NAD+ in the Development of Non-alcoholic Fatty Liver Disease
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Evolving roles of CD38 metabolism in solid tumour microenvironment | British Journal of Cancer
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Metabolic Dysfunction Drives a Mechanistically Distinct Proinflammatory Phenotype in Adipose Tissue Macrophages - ScienceDirect
Novel Markers to Delineate Murine M1 and M2 Macrophages
Expression of CD38 and Egr2 protein in M0, M1 and M2 macrophages.
Reprogramming of macrophages with macrophage cell membrane-derived nanoghosts - Nanoscale Advances (RSC Publishing) DOI:10.1039/D0NA00572J
The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline. - Abstract - Europe PMC
Increased CD38 expression in human M(LPS + IFN-γ) monocyte-derived... | Download Scientific Diagram
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer
CD38 and other M1 markers in macrophages treated with SASP. (A)... | Download Scientific Diagram
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE